Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nil Banu Pelit"'
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Omur Selin Gunaydin, Nihal Ozturk Sahin, Esra Savas Karagacli, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu Sen, Zeynep Torun, Utku Seyis, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
BACKGROUND The efficacy of SARS-CoV2 single donor convalescent plasma (CP) varied according to the application time and the amount of antibody that is administered. Single donor CP has some drawbacks; such as the insufficient levels of neutralizing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3286eaecda19042444d50d795e508c
https://doi.org/10.21203/rs.3.rs-1042702/v3
https://doi.org/10.21203/rs.3.rs-1042702/v3
Autor:
Raife Dilek Turan, Omur Selin Gunaydin, Muhammer Elek, Nil Banu Pelit, Ercument Ovali, Sefa Onur Demir, Rehile Zengin, Miyase Ezgi Kocaoglu, Cihan Tastan, Nur Birgen, Nihal Ozturk Sahin, Selen Abanuz, Esra Savas Karagacli, Caglar Cuhadaroglu, Goncagul Celebi, Bulut Yurtsever, Derya Dilek Kancagi, Cansu Hemsinlioglu, Gozde Sir Karakus, Koray Yalcin, Evren Safak, Ayse Sesin Kocagoz, Siret Ratip, Zeynep Torun, Omer Elibol, Didem Cakirsoy, Utku Seyis
Introduction The efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10f5eff4215dd3b7996e4caf620d74dc
https://doi.org/10.21203/rs.3.rs-1042702/v1
https://doi.org/10.21203/rs.3.rs-1042702/v1
Autor:
Richard Gammon, Pierre Gallian, J. N. S. Leung, David J. Roberts, Karin van den Berg, James Daly, Robby Nur Aditya, Michel Toungouz Nevessignsky, Rekha Hans, Paula Verónica Cini, Pierre Tiberghien, Levent Sagdur, Nil Banu Pelit, Gopal Kumar Patidar, Nancy M. Dunbar, Eilat Shinar, Ivan Hung, Carlos Alberto Gonzalez, Richard Schäfer, Rita A. Reik, Hua Xu, Ru Yang, Khuloud Al Maamari, Salwa Hindawi, Naomi Rahimi-Levene, Patricia Scuracchio, Rahul Chaurasia, Sinyoung Kim, Marion Vermeulen, Hans Vrielink, Lise Sofie H. Nissen-Meyer, Mark H. Yazer, Melissa Lopez, Jarkko Ihalainen, Silvano Wendel, Vincenzo De Angelis, Pampee P. Young, Ratti Ram Sharma, Cynthia So-Osman, Antti Vierikko, Hem Chandra Pandey, Ai Leen Ang, Yan Qiu, Angelo Ostuni, Renée Bazin, Cheuk-Kwong Lee, Giuseppe Marano, Zaid Al-Hinai, Roberta Fachini, Pascal Morel, Marina Izak, Lise J Estcourt, Pierluigi Berti, Tanya Nadia Glatt, David Martin Ferrari, Thierry Burnouf, Veronica C. Hoad, Maha A. Badawi, Levent Tufan Kumaş, Magdy El Ekiaby, Vernon J. Louw, Darrell J. Triulzi, Arwa Z. Al-Riyami, Divjot Singh Lamba, Suchet Sachdev, Kiat Hoe Ong, Dana V. Devine, Sheila Maclennan
Publikováno v:
Vox Sanguinis
Vox Sanguinis, Wiley, 2021, ⟨10.1111/vox.13114⟩
Vox Sanguinis, Wiley, 2021, ⟨10.1111/vox.13114⟩
International audience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e86d25a1256a89f17624380d286691
https://doi.org/10.1111/vox.13114
https://doi.org/10.1111/vox.13114
Autor:
Cansu Hemsinlioglu, Nil Banu Pelit, Koray Yalcin, Omur Selin Gunaydın, Nihal Ozturk Sahin, Esra Savas Karagacli, Omer Elibol, Sefa Onur Demir, Evren Safak, Raife Dilek Turan, Goncagul Celebi, Miyase Ezgi Kocaoglu, Gozde Sir Karakus, Bulut Yurtsever, Cihan Tastan, Selen Abanuz, Didem Cakirsoy, Derya Dilek Kancagi, Zeynep Torun, Utku Seyis, Muhammer Elek, Rehile Zengin, Ayse Sesin Kocagoz, Caglar Cuhadaroglu, Nur Birgen, Siret Ratip, Ercument Ovali
IntroductionThe efficacy of SARS-CoV2 standard single donor convalescent plasma varied according to the application time and most importantly the amount of antibody that is administered. Single donor plasma has some drawbacks; such as the insufficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19814f32a500e48d0aeba4155ed87953
https://doi.org/10.1101/2021.03.05.21251413
https://doi.org/10.1101/2021.03.05.21251413
Autor:
Koray Yalcin, Cansu Hemsinlioglu, Rehile Zengin, Meral Sonmezoglu, Riza Hakan Erbay, Fatih Sargin, Aysin Ersoy, Bulent Baris Guven, Bulent Tutluoglu, Nur Kaskir Ozturk, Hande Aygun, Reha Baran, Hulya Kusoglu, Oner Dikensoy, Sezen Ozkok, Muhammed Yilanci, Nur Birgen, Nil Banu Pelit, Hacer Kuzu Okur, Caglar Cuhadaroglu, Ayse Sesin Kocagoz, Ercument Ovali
UNSTRUCTURED The novel coronavirus disease 2019 (COVID-19) continues to spread over the world and there is still no specific treatment. Beside many drug studies, there is not enough data about the place of cellular therapies. In this study, we used s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d618c165264b92f31eb2bde6c9fb05f4
https://doi.org/10.2196/preprints.20206
https://doi.org/10.2196/preprints.20206
Autor:
Sevil, Uygun Ilikhan, Muammer, Bilici, Hatice, Sahin, Ayse, Semra Demir Akca, Huseyin, Engin, Cemil, Bilir, Nergis, Sevinc, Nil, Banu Pelit, Ishak, Ozel Tekin
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 20(2)
Hepatocellar carcinoma (HCC) remains a major health problem being the third leading cause of deaths due to cancer worldwide. Because HCC is known to be highly resistant to conventional systemic therapies, single-agent or combination of systemic thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5761c09c55947bd8556a5e7b37833bd
https://pubmed.ncbi.nlm.nih.gov/26011357
https://pubmed.ncbi.nlm.nih.gov/26011357